跳至主要内容
临床试验/NCT02512939
NCT02512939已完成不适用

Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection

University College, London5 个研究点 分布在 1 个国家目标入组 675 人开始时间: 2015年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
675
试验地点
5
主要终点
assess prognostic ability of blood test by assessing development of active TB disease compared to the current gold standard

研究概览

简要总结

This study will assess the next generation of blood tests for latent TB infection, which may be able to indicate how treatment is working as well as in diagnosis infection.

详细描述

Currently available blood tests for latent tuberculosis infection (LTBI) identify people who have been previously infected with M. tuberculosis. Whilst they are sensitive and specific, they cannot be used to monitor the effectiveness of treatment for LTBI. New blood tests ("fourth generation Quantiferon tests") give a more complete measurement of the workings of the immune system, which may be useful to show whether treatment is working. These new tests have not yet been evaluated in clinical practice, so their usefulness in identifying people at highest risk of TB disease and monitoring treatment is unknown.

Mass gatherings, such as the annual Hajj pilgrimage, may encourage the spread of infectious diseases, including respiratory infections such as influenza, respiratory syncytial virus, and possibly also tuberculosis. However, the risk of TB infection during the Hajj has not been reliably measured. It is important to measure this risk so that pilgrims can be given suitable advice about preventing infection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Contacts: Adult (aged 16 years or older) contacts of smearpositive pulmonary TB patients attending participating TB clinics or primary care centres for screening will be invited to take part. Contacts will include all individuals with a cumulative duration of exposure of greater than eight hours to the relevant index case in a confined space during the period of infectiousness (prior to initiation of treatment). Patients with active TB: Newly diagnosed, microbiologically confirmed tuberculosis disease (pulmonary or extrapulmonary) attending participating TB clinics or primary care centres. Hajj pilgrims: Individuals arranging travel to Saudi Arabia for the Hajj through participating tour operators.

排除标准

  • •Contacts: Active TB disease. Individuals who are unable to give informed consent. Children aged under 16 years.
  • •TB cases: Individuals who are unable to give informed consent. Children aged under 16 years.
  • •Hajj pilgrims: Active TB disease. Any health indication which would prevent travel to Saudi Arabia. Individuals who are unable to give informed consent. Children aged under 16 years.

研究组 & 干预措施

Contacts of TB cases

Experimental

Blood test, not yet marketed, development phase

干预措施: blood test, not yet marketed, no trade name (Procedure)

结局指标

主要结局

assess prognostic ability of blood test by assessing development of active TB disease compared to the current gold standard

时间窗: 1 year

assess prognostic ability of blood test by assessing development of active TB disease.

次要结局

  • estimate the risk of infection with M. tuberculosis and other respiratory pathogens amongst UK pilgrims undertaking the Hajj.(1 year)
  • assess the sensitivity of new blood tests for detecting TB infection in patients with active TB disease compared to teh current godl standard(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验